Background: Transjugular intrahepatic portosystemic shunts (TIPS) have been used to control symptomatic portal hypertension in patients awaiting liver transplant. Although their role in pretransplantation patients is well established, their role in posttransplantation patients is unclear. Study Desi
Liver infarction after transjugular intrahepatic portosystemic shunt in a liver transplant recipient
β Scribed by Meng Y. Wang; Darryn R. Potosky; Sandeep Khurana
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 874 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
A 44-year-old man with a history of cirrhosis secondary to hepatitis C, status post orthotopic liver transplantation in 2001, with recurrent graft cirrhosis and end-stage renal disease on hemodialysis (Model for End-Stage Liver Disease 29) presented with massive variceal hemorrhage. Despite endoscopic band ligation, he bled aggressively and required Minnesota
Fig.
π SIMILAR VOLUMES
This study was designed to evaluate the impact of transjugular intrahepatic portosystemic shunts (TIPS) on liver transplantation. Historically, the complications of portal hypertension have been temporized with sclerotherapy or surgical portosystemic shunts. In patients whose liver disease progresse
Hepatic hydrothorax is a relatively infrequent but potentially serious complication of cirrhosis resulting from the accumulation of ascitic fluid in the chest cavity. Medical management is initially directed at controlling ascites formation, but invasive therapeutic procedures may be required if sym
The role of transjugular intrahepatic portosystemic shunt (TIPS) insertion in managing the complications of portal hypertension is well established, but its utility in patients who have previously undergone liver transplantation is not well documented. Twentytwo orthotopic liver transplantation (OLT
Sinusoidal obstruction syndrome (SOS) is a rare, life-threatening clinical syndrome resulting from sinusoidal congestion, and it is characterized by hepatomegaly, ascites, weight gain, and jaundice. The frequency of this condition after liver transplantation (LT) is low, but when SOS is severe and r
The authors correctly caution that their prognostic score must be externally validated before use in a clinical setting. Hopefully, with further studies and validation, a recommendation can be made on which patients with BCS should proceed beyond TIPS in a timely manner to liver transplantation.